Congress is considering MFN price control policy that would tie U.S. prescription drug payments to pricing in countries with socialized medicine.
In plain terms, that means importing socialist price controls into American law.
Price controls ALWAYS fail.
MFN would:
- Cede ground to China in the biotech arms race
- Undermine American medical innovation
- Reduce incentives for research and development
- Delay future breakthroughs
America wins with free enterprise, not socialist price controls.
Take Action: Tell Congress to reject MFN price controls and protect American biotech leadership.
It takes less than a minute.